País: Malàisia
Idioma: anglès
Font: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
TERAZOSIN HCL DIHYDRATE
DUOPHARMA (M) SDN. BHD.
TERAZOSIN HCL DIHYDRATE
100 Tablets
DUOPHARMA (M) SDN. BHD.
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ _ _ RALSIN TABLET Terazosin Hydrochloride (2mg, 5mg) _ _ 1 WHAT IS IN THIS LEAFLET 1. What RALSIN TABLET is used for 2. How RALSIN TABLET works 3. Before you use RALSIN TABLET 4. How to use RALSIN TABLET 5. While you are using RALSIN TABLET 6. Side effects 7. Storage and disposal of RALSIN TABLET 8. Product description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT RALSIN TABLET IS USED FOR RALSIN TABLET is used to treat a condition called benign prostatic hyperlapsia (BPH). In this condition there is enlargement of the prostate gland, which leads to difficulty passing urine. RALSIN TABLET also used to treat high blood pressure. HOW RALSIN TABLET WORKS RALSIN TABLET helps to relieve the obstruction in the prostate gland and improves the flow of urine. BEFORE YOU USE RALSIN TABLET _-_ _ _ _When you must not use it _ Do not use RALSIN TABLET if you are allergic to Terazosin Hydrochloride or any of the other ingredients listed at the end of the leaflet. _-_ _ _ _Before you start to use it _ Before taking RALSIN TABLET, you must tell your doctor or pharmacist if you have, or have had, any of the following conditions: • Allergic to any similar medications such as prozasin, other medicines, foods, dyes or preservatives. • Any heart problems • Low blood pressure If you are not sure if you have, or have had, any of these conditions, you should raise those concerns with your doctor or pharmacist. _Pregnancy _ Ask for your doctor’s advice if you are pregnant, or likely to become pregnant during your course of medication. RALSIN TABLET is not recommended for pregnant women. _Breastfeeding _ Ask for your doctor’s advice if you are breastfeeding, or likely to breastfeed during your course of medication. Caution should be exercised when RALSIN TABLET is administered to nutrsing women. _-_ _ _ _Taking other medicines _ Inform your doctor or pharmacist before taking RALSIN TABLET. Before using RALSIN TABLET, it is important to tell your docto Llegiu el document complet
[DUOPHARMA (M) SDN BHD] Page 1 of 2 [REVISION DATE: 12.06.2019] RALSIN TABLET DESCRIPTION: RALSIN TABLET 2 MG: A blue, round tablet (diameter 7 mm) with ‘DUOMA/DUOMA’ & SCORED marking. RALSIN TABLET 5 MG: A green, round tablet (diameter 7 mm) with ‘DUOMA/DUOMA’ & SCORED marking. COMPOSITION: RALSIN TABLET 2 MG: Each tablet contains Terazosin hydrochloride dihydrate equivalent to Terazosin 2 mg. RALSIN TABLET 5 MG: Each tablet contains Terazosin hydrochloride dihydrate equivalent to Terazosin 5 mg. PHARMACODYNAMICS: Terazosin hydrochloride is an α-1 selective adrenoceptor blocking agent. Blockade of α-1 adrenergic receptors inhibits vasoconstriction induced by endogenous catecholamines; vasodilation may occur in both arteriolar resistance vessels and veins. The result is a fall in blood pressure because of decreased peripheral resistance. Terazosin is chemically related to prazosin and acts primarily by blocking α-1 adrenoceptors. It has similar pharmacodynamics effects to prazosin but a longer duration of action which enables once daily dosing. Terazosin has been shown to have neutral or possibly slightly beneficial effects on plasma lipids. In animals, terazosin causes a decrease in blood pressure by decreasing total peripheral vascular resistance. Terazosin decreases blood pressure gradually within 15 minutes following oral administration. In man, systolic and diastolic blood pressures are lowered in both the supine and standing positions. The effect is most pronounced on the diastolic blood pressure. These changes are usually not accompanied by reflex tachycardia. A greater blood pressure effect associated with peak plasma concentration (first few hours after dosing) appears somewhat more position dependent (greater in the erect position) than the effect of terazosin at 24 hours, and in the erect position there is also a 6-10 beat per minute increase in heart rate in the first few hours after dosing. Studies suggest that α-1 adrenoceptor blockade is also useful in improving the urodynamics in patie Llegiu el document complet